Current autoregressive LLMs are a dead end for achieving AGI because they lack the ability to understand the world, plan, or reason about the consequences of their actions.
The future of AI lies in Joint Embedding Predictive Architectures (JEPAs) and World Models, which can learn causal models of the world to enable true reasoning and planning.
Open-source AI platforms are fundamentally superior to closed, proprietary models and will ultimately dominate the industry, analogous to how open operating systems displaced proprietary ones.
Fears of existential AI risk are exaggerated and are being leveraged by companies like Anthropic to lobby for regulations that would stifle competition from open-source models.
Large corporate environments, when under intense pressure to deliver short-term product results, can stifle the long-term, exploratory research necessary for fundamental breakthroughs in AI.
Early 2023
Meta establishes the GenAI organization to productize the LLaMA-1 model developed at its FAIR research lab.
2023
LeCun's views on AI begin to diverge from his fellow Turing Award winners. This coincides with Geoffrey Hinton's shift in perspective on AI risk following the release of GPT-4.
Mid-2023
Amidst significant internal debate with Meta's legal and policy departments, LeCun successfully argues for the open-sourcing of LLaMA 2.
Throughout 2023
The GenAI organization at Meta, under intense short-term pressure to compete, becomes conservative and siloed from the FAIR research lab, hindering innovation.
Late 2023
Mark Zuckerberg's disappointment with the LLaMA-4 model prompts a major reorganization. Meta's strategy shifts to catching up with competitors, deprioritizing exploratory research.
Late 2023 / Early 2024
Concluding that Meta is no longer the right environment for his research on world models, LeCun leaves the company to found his own venture, Emilabs.
▶Critique of the LLM ParadigmApr–Jun 2026
LeCun argues that the current dominant approach of scaling autoregressive LLMs is fundamentally flawed. He believes these models cannot truly understand the world, plan, or reason about the consequences of their actions, and will therefore hit an asymptote long before reaching human-level intelligence.
Investors should be aware of this credible, alternative thesis that the current multi-trillion dollar buildout based on scaling LLMs may be a technological dead end, posing a significant risk to incumbents heavily invested in this single approach.
▶Advocacy for World Models and JEPAApr–May 2026
As an alternative to LLMs, LeCun champions Joint Embedding Predictive Architectures (JEPAs) and the concept of World Models. These systems are designed to learn internal models of how the world works, enabling them to predict outcomes and plan actions, which he sees as the true path to agentic, intelligent systems.
LeCun's new venture, Emilabs, is a pure-play bet on this alternative architecture, and its progress could serve as a leading indicator for a potential paradigm shift away from generative, token-prediction models.
▶The Politics and Business of Open-Source AIJul 2026
LeCun is a vocal proponent of an open AI ecosystem, comparing proprietary models from OpenAI and Anthropic to the closed computer systems of the 1990s that were eventually displaced by open platforms. He actively fought for open-sourcing LLaMA 2 at Meta and criticizes competitors for using safety concerns to lobby for regulations that would stifle open competition.
The tension between open and closed AI models represents a fundamental strategic battle. LeCun's stance suggests that companies building on or contributing to open models may have a long-term strategic advantage if his historical analogy proves correct.
▶Corporate Dysfunction and the Pursuit of ResearchMay 2026
LeCun's departure from Meta was precipitated by the company's strategic shift to catch up with competitors, which deprioritized long-term exploratory research. He describes how the product-focused GenAI group became conservative and siloed from the FAIR research lab, and how disappointment with LLaMA-4 led to a reorganization that ultimately convinced him Meta was no longer the right place to pursue his vision.
This narrative highlights the inherent conflict between short-term product pressures and long-term, fundamental research within large tech corporations, suggesting that major breakthroughs may increasingly come from more focused, independent labs like his own Emilabs.